Common antidepressant eases fatigue associated with long COVID, study finds

A global research team co‑led by McMaster University has identified one of the first medications shown to meaningfully reduce fatigue in people living with long COVID—a breakthrough for millions still struggling with persistent symptoms years after the pandemic began.